ADC Therapeutics SA Common Shares (ADCT)
1.7300
+0.0100 (0.58%)
Adc Therapeutics is a biotechnology company focused on the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancers
The company leverages its proprietary technology platform to create innovative therapies that specifically target and kill cancer cells while sparing healthy tissue, thereby enhancing treatment efficacy and reducing side effects. Adc Therapeutics aims to address unmet medical needs in oncology by advancing its pipeline of drug candidates through clinical trials, and its research efforts are guided by a commitment to improve patient outcomes in various types of malignancies.
Frequently Asked Questions
Is ADC Therapeutics SA Common Shares publicly traded?
Yes, ADC Therapeutics SA Common Shares is publicly traded.
What exchange does ADC Therapeutics SA Common Shares trade on?
ADC Therapeutics SA Common Shares trades on the New York Stock Exchange
What is the ticker symbol for ADC Therapeutics SA Common Shares?
The ticker symbol for ADC Therapeutics SA Common Shares is ADCT on the New York Stock Exchange
What is the current price of ADC Therapeutics SA Common Shares?
The current price of ADC Therapeutics SA Common Shares is 1.730
When was ADC Therapeutics SA Common Shares last traded?
The last trade of ADC Therapeutics SA Common Shares was at 10:30 am EST on January 31st, 2025
What is the market capitalization of ADC Therapeutics SA Common Shares?
The market capitalization of ADC Therapeutics SA Common Shares is 132.73M
How many shares of ADC Therapeutics SA Common Shares are outstanding?
ADC Therapeutics SA Common Shares has 76.72M shares outstanding.